نتایج جستجو برای: release agents

تعداد نتایج: 561374  

Assal Mir Mohammad Sadeghi Mohammad Reza Avadi Morvarid Goharzadeh Orkide Ghorban Dadras

In the past decade, many strategies have been developed to enhance oral drug delivery. Different techniques were investigated, amongst those the use of permeation enhancers such surfactants and biodegradable polymers were studied more extensively. Chitosan derivatives have been studied as permeation enhancer in free soluble form and as nanoparticulate systems. The aim of the current work wa...

2015
Richard B. Rothman Subramaniam Ananthan John S. Partilla Surendra K. Saini Omar Moukha-Chafiq Vibha Pathak Michael H. Baumann

Novel allosteric modulators of the dopamine transporter (DAT) have been identified. We have shown previously that SRI-9804 [N-(diphenylmethyl)-2-phenyl-4-quinazolinamine], SRI-20040 [N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine], and SRI-20041 [N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine] partially inhibit [I]RTI-55 ([I]3b-(49-iodophenyl)tropan-2b-carboxylic acid methyl ester) binding...

Journal: :npj Materials degradation 2022

The easy and scalable synthesis, biocompatibility, one-dimensionality, high aspect ratio, viability for surface modifications, the ability cargo-loading release make organic nanotubes ideal candidates smart coatings with slow controlled corrosion inhibitors anti-biofouling agents. wide-ranging applicability of as nanocarriers anti-corrosion is foreseen.

Journal: :Journal of Crohn's & colitis 2012
Ulf Helwig Michael Müller Jürgen Hedderich Stefan Schreiber

INTRODUCTION Latent tuberculosis infection is detected by the tuberculin skin test before treating with anti-Tumour-Necrosis factor alpha (anti TNFα) reagents. More accurate are Interferon gamma release assays (IFNγ release assays) to identify patients with latent tuberculosis. Because of a positive control in this assay, it is possible to identify those patients in which a result of tuberculos...

پایان نامه :دانشگاه آزاد اسلامی - دانشگاه آزاد اسلامی واحد علوم دارویی - دانشکده پزشکی 1393

داروی آلفازوسین متعلق به دسته داروهای قلبی عروقی می باشد که در درمان هایپرپلازی خوش خیم پروستات به عنوان خط اول درمان مطرح می باشد. این دارو به شکل قرص های immediate release با دوز 5/2 میلی گرم و قرص های extended release با دوزهای 5 و 10 میلی گرم موجود می باشد. از انجایی که این دارو با قابلیت درمانی بالا در کشور ما تولید نمی شود هدف ما بر این است که با تهیه فرمولاسیون فرم آهسته رهش این قرص با...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید